Sort   by:  
 Page size 
UnknownAdaptive Randomization of Neratinib in Early Breast Cancer.
Not available
S-EPMC5259558 | biostudies-literature
UnknownAdaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Not available
S-EPMC5259561 | biostudies-literature
UnknownBaricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
Not available
S-EPMC7745180 | biostudies-literature
UnknownGenomic Ascertainment of CHEK2-Related Cancer Predisposition.
Not available
S-EPMC12706675 | biostudies-literature
UnknownEfficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279 | biostudies-literature
UnknownResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931 | biostudies-literature
UnknownA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100 | biostudies-literature
UnknownThe Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Not available
S-EPMC9447373 | biostudies-literature
UnknownEarly trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Not available
S-EPMC11181148 | biostudies-literature
UnknownViral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Not available
S-EPMC11175705 | biostudies-literature
Sort   by:  
 Page size